ORLANDO, Fla. — Of the 12 biologics in four drug classes approved for treating psoriasis in the United States, interleukin 23 (IL-23) inhibitors might be exceptional, particularly if used early ...

ORLANDO, Fla. — Adults with moderate to severe plaque psoriasis taking the novel oral drug icotrokinra had significant improvement starting at week 16, with increased response rates continuing ...

Psoriasis can cause patches of skin that itch, burn, or sting. Petroleum jelly may help hydrate the skin and relieve psoriasis symptoms. Petroleum jelly is an odorless, semisolid mixture of ...

Itchy hands and feet can be caused by dry skin and different conditions, including eczema, allergic reactions, psoriasis, diabetes ... On the back of the hand, the rash may appear as scaly red, itchy ...

So do potential off-label uses of existing drugs, including IL-17 inhibitors. Hives (urticaria) are a type of rash that causes raised, red, itchy bumps or welts. Hives may be acute, appearing quickly ...

Johnson & Johnson’s once-daily oral peptide has bested Bristol Myers Squibb’s reigning oral psoriasis med Sotyktu in a pair of phase 3 trials. The Protagonist Therapeutics-partnered IL-23 ...

Late-stage data also showed that Johnson & Johnson’s icotrokinra was superior to Bristol Myers Squibb’s Sotyktu at clearing skin and easing symptom severity in patients with plaque psoriasis. Johnson ...